IPF Management in Practice: A Truly Interactive Experience

Released On
December 18, 2020

Expires On
December 18, 2021

Media Type
Internet

Completion Time
60 minutes

Specialty
Allergy & Immunology, Critical Care, Infectious Disease, Pathology, Primary Care, Pulmonology, and Surgery

Topic(s)
Pharmacology, Radiology, Respiratory, and Surgery

Scroll to the Bottom of this Information to Begin this Course

This activity is provided by The France Foundation.

 

This activity is supported by independent education grants from Boehringer Ingelheim Pharmaceuticals, Inc., and Genentech.

Credit Available

  • Physicians—Maximum of 1.00 AMA PRA Category 1 Credit(s)

All other health care professionals completing this course will be issued a statement of participation.

Target Audience

This activity is designed to meet the educational needs of pulmonologists, primary care providers, and other health care providers who manage patients with IPF.

Program Overview

This highly interactive activity will cover the real life challenges of managing patients with Idiopathic Pulmonary Fibrosis.

The unique learning environment will include:

  • Scenarios and simulations
  • Unique knowledge checks
  • Visually dynamic presentation of content

 

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Discuss timing and rationale for starting antifibrotic therapy
  • Decide when to stop or switch treatment
  • Recognize the side effects associated with antifibrotic use
  • Discuss disease progression treatment expectations and the importance of adhering to treatment
  • Review common IPF comorbidities and their effective management

Faculty

Amy Hajari Case, MD

Director of the Advanced Lung Disease Program and Medical Director of Pulmonary and Critical
Care Research
Piedmont Healthcare
Austell, GA
Link to Bio https://doctors.piedmont.org/provider/Amy+Hajari+Case/391030

Mridu Gulati, MD

Associate Director of the Yale Interstitial Lung Disease Program
New Haven, CT
Link to Bio https://medicine.yale.edu/profile/mridu_gulati/

Accreditation Statement

The France Foundation is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation

The France Foundation designates this enduring activity for a maximum of 1.0 AMA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the enduring activity.

Nurses:
Nurses who are certified by the American Nurses Credentialing Center (ANCC) may utilize activities that are certified by ACCME-accredited providers toward their requirement for certification renewal by the ANCC. A certificate of attendance will be provided by The France Foundation, an ACCME accredited provider.

Disclosures of Conflicts of Interest

Amy Hajari Case, MD

  • Speaker's Bureau: Boehringer Ingleheim Pharmaceuticals, Inc. and Genentech
  • Contract Research: Boehringer Ingleheim Pharmaceuticals, Inc, Bellerophon, Galapagos, Gilead, Kadmon, Kinevant, and United Therapeutics
  • Employment Relationship: Pulmonary Fibrosis Foundation

Mridu Gulati, MD

  • Consulting: Boehringer Ingleheim Pharmaceuticals, Inc. and The Pulmonary Fibrosis Foundation

Instructions for Participation and Credit

 

  1. There are no fees for participating in and receiving credit for this activity
  2. Review the activity objectives and CME/CE information
  3. Complete the CME/CE activity
  4. Complete the online posttest. A score of at least 75% is required to successfully complete this activity. The participant may take the test until successfully passed.
  5. Complete the CME/CE evaluation/attestation form. This form provides each participant with the opportunity to comment on how participating in the activity will affect their professional practice; the quality of the instructional process; the perception of enhanced professional effectiveness; the perception of commercial bias; and his/her views on future educational needs.
  6. Credit documentation/reporting:
    • If you are requesting AMA PRA Category 1 Credits™ or a certificate of participation—your CME/CE certificate will be available for download after completing the evaluation

 

Course Viewing Requirements

Supported Browsers:
Internet Explorer 8.0+ for Windows 2003, Vista, XP, Windows 7, and Windows 8.1 and above
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 6.0+ for Mac OSX 10.7 and above

Supported Phones & Tablets:
Android 4.0.3 and above
iPhone/iPad with iOS 6.1 or above

Disclosure of Unlabeled Use

The France Foundation requires CME faculty (speakers) to disclose when products or procedures being discussed are off label, unlabeled, experimental, and/or investigational, and any limitations on the information that is presented, such as data that are preliminary, or that represent ongoing research, interim analyses, and/or unsupported opinion. Faculty in this activity may discuss information about pharmaceutical agents that is outside of US Food and Drug Administration approved labeling. This information is intended solely for continuing medical education and is not intended to promote off-label use of these medications. TFF does not recommend the use of any agent outside of the labeled indications. If you have questions, contact the Medical Affairs Department of the manufacturer for the most recent prescribing information.

Disclaimer

The France Foundation presents this information for educational purposes only. The content is provided solely by faculty who have been selected because of recognized expertise in their field. Participants have the professional responsibility to ensure that products are prescribed and used appropriately on the basis of their own clinical judgment and accepted standards of care. The France Foundation and the commercial supporter assume no liability for the information herein.

Contact Information

For CME questions please contact: info@francefoundation.com